Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 February 2020 | Story Ruan Bruwer | Photo Varsity Cup
William Eybers read more
Centre William Eybers is the new captain of the Shimlas.

With an experienced squad at its disposal, the Shimla team is approaching the 2020 Varsity Cup with confidence – despite a very difficult first assignment.

The 13th version of the student rugby competition starts on Monday (3 February), with the University of the Free State team travelling to Stellenbosch to face the champions of the previous two years, Maties.

The Shimlas retained 19 players from last year’s team. This is compared to the previous two campaigns where they had little experience and a bunch of very young players. Head coach Hendro Scholtz can call upon ten players who have played in this competition before and who know what it is all about.
Even more important is that the ten senior men are playing in key positions, such as the hooker (Hanno Snyman), eighth man (Mihlali Peter and Bertie de Bod), scrumhalf (Rewan Kruger), and fullback (Ruan Henning). Snyman will participate in his fourth Varsity Cup.

The Shimlas have a new leader in centre William Eybers in 2020. He was named joint best backline player for 2019 at last year’s Shimla Rugby Club prize-giving ceremony.
The Shimlas won four of their eight matches in 2019 to book in spot in the semi-finals against Maties.

Monday’s encounter starts at 19:15 in the Danie Craven Stadium. The match will be broadcast live on SuperSport. The remaining Shimla fixtures are: 10 February against UWC (home), 17 February against NWU (away), 24 February against Tuks (away), 2 March against Ixias (home), 9 March against UJ (home), 16 March against Ikeys (away), 30 March against Wits (home).

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept